Recently, Estée Lauder UK and Ireland has reported a significant downturn in its financial performance for the year ending in June, with the company swinging to a notable loss.
Its turnover fell to £526.2 million, down from £542.2 million the previous year. The cost of sales increased, leading to a reduction in gross profit from £369 million to £337 million. Operating income saw a sharp drop of 27%, down to £67.5 million, and the company’s loss before tax amounted to £364.7 million, compared to a profit of £115.4 million the year before. The net loss for the year stood at £379 million, a stark contrast to the £93 million profit reported in the previous year.
Profits also took a severe hit, with the company’s profit after tax plummeting by 480%. However, much of this loss can be traced back to a one-off impairment related to Estée Lauder’s investment in Have & Be Co Ltd, the parent company of Dr Jart+, which Lauder acquired in 2019. This impairment, amounting to £439 million, stemmed from the strategic decision to exit the travel retail channel globally for the Dr Jart+ brand.
Despite the significant loss, the company pointed out that one-off events, particularly the impairment and the change in dividend payments from Have & Be, were primarily responsible for the sharp financial downturn. Estée Lauder’s parent company in the U.S. is also undergoing restructuring, with recent reports indicating that more jobs than previously anticipated will be cut globally. The company employs around 4,400 people in the UK and Ireland, part of its tens of thousands of employees worldwide.
